Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
作者： Lisa K Dunnwald , Mary Anne Rossing , Christopher I Li
DOI: 10.1186/BCR1639
关键词:
摘要: Background Breast cancer patients with tumors that are estrogen receptor (ER)-positive and/or progesterone (PR)-positive have lower risks of mortality after their diagnosis compared to women ER- PR-negative disease. However, few studies evaluated variations in the breast cancer-specific across ER/PR status by either demographic or clinical characteristics.
springer.com
biomedcentral.com
breast-cancer-research.com参考文章(37)
C. A. Hubay, D. J. Brumberg, Robert R. Shenk, N. H. Gordon, Jerry M. Shuck, Joseph Crowe, R. M. Zollinger, W. L. McGuire, Estrogen receptor determination and long term survival of patients with carcinoma of the breast. Surgery gynecology & obstetrics. ,vol. 173, pp. 273- 278 ,(1991)
William F. Anderson, Kenneth C. Chu, Nilanjan Chatterjee, Otis Brawley, Louise A. Brinton, Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. Journal of Clinical Oncology. ,vol. 19, pp. 18- 27 ,(2001) , 10.1200/JCO.2001.19.1.18
Vijayluxmi Karnan, Dharamraj Nirmul, Rosemary J. Pegoraro, Septimus M. Joubert, Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Research. ,vol. 46, pp. 2117- 2120 ,(1986)
Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1474- 1474 ,(1999) , 10.1200/JCO.1999.17.5.1474
B Fisher, C Redmond, E R Fisher, R Caplan, Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. Journal of Clinical Oncology. ,vol. 6, pp. 1076- 1087 ,(1988) , 10.1200/JCO.1988.6.7.1076
William L. Donegan, Prognostic factors: Stage and receptor status in breast cancer Cancer. ,vol. 70, pp. 1755- 1764 ,(1992) , 10.1002/1097-0142(19920915)70:4+<1755::AID-CNCR2820701617>3.0.CO;2-G
Aron Goldhirsch, William C. Wood, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, Hans-Jörg Senn, Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer Journal of Clinical Oncology. ,vol. 21, pp. 3357- 3365 ,(2003) , 10.1200/JCO.2003.04.576
Victor R. Grann, Andrea B. Troxel, Naseem J. Zojwalla, Judith S. Jacobson, Dawn Hershman, Alfred I. Neugut, Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer. ,vol. 103, pp. 2241- 2251 ,(2005) , 10.1002/CNCR.21030
Ellen Warner, Breast-Cancer Screening New England Journal of Medicine. ,vol. 365, pp. 1025- 1032 ,(2011) , 10.1056/NEJMCP1101540
Fritz F. Parl, B. Peter Schmidt, William D. Dupont, Rüdiger K. Wagner, Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading Cancer. ,vol. 54, pp. 2237- 2242 ,(1984) , 10.1002/1097-0142(19841115)54:10<2237::AID-CNCR2820541029>3.0.CO;2-V